510(k) K903531
K903531 is an FDA 510(k) premarket notification submitted by Medical Innovations Corp. for the device "ANTICARDIOLIPIN ANTIBODY TEST SYSTEM". The FDA issued a decision of Substantially Equivalent on Jan 25, 1991. The device falls under product code GFO (Activated Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Medical Innovations Corp. has 23 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 25, 1991
- Date Received
- Aug 6, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Activated Partial Thromboplastin
- Device Class
- Class II
- Regulation Number
- 864.7925
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Medical Innovations Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.